Nektar Therapeutics - Current Ratio

The Current Ratio as of September 2026 (TTM) for Nektar Therapeutics (0UNL.L) is 10.42

According to Nektar Therapeutics’s latest financial reports and current stock price. The company's current Current Ratio is 10.42. This represents a change of 39.64% compared to the average of 7.46 of the last 4 quarters.

Nektar Therapeutics (0UNL.L) Historical Current Ratio (quarterly & annually)

How has 0UNL.L Current Ratio performed in the past?

The mean historical Current Ratio of Nektar Therapeutics over the last ten years is 7.61. The current 10.42 Current Ratio has changed 13.58% with respect to the historical average. Over the past ten years (40 quarters), 0UNL.L's Current Ratio was at its highest in in the June 2018 quarter at 19.67. The Current Ratio was at its lowest in in the June 2025 quarter at 2.61.

Nektar Therapeutics (0UNL.L) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nektar Therapeutics Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nektar Therapeutics (0UNL.L) Average Current Ratio

How has 0UNL.L Current Ratio performed in the past?

The current Current Ratio of Nektar Therapeutics (0UNL.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nektar Therapeutics (0UNL.L) Current Ratio vs. Peers

How is 0UNL.L’s Current Ratio compared to its peers?

Nektar Therapeutics’s Current Ratio is greater than OPKO Health, Inc. (3.35), greater than Dynavax Technologies Corporation (7.62), greater than Intellia Therapeutics, Inc. (6.65), greater than Axogen, Inc. (6.60), greater than Verastem, Inc. (2.25), greater than Geron Corporation (6.92), less than Anavex Life Sciences Corp. (15.62), greater than Iovance Biotherapeutics, Inc. (4.35), greater than Myriad Genetics, Inc. (2.21), greater than Teladoc Health, Inc. (0.83),

Build a custom stock screener for Nektar Therapeutics (0UNL.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nektar Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nektar Therapeutics (0UNL.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nektar Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.